|
|
- American Academy of Psychiatric Association. Diagnostic and Statistical Manual for Mental Disorders. 4th ed. Washington, DC. American Psychiatric Association, 1994:78-85.
- National Institute of Mental Health. Attention Deficit Hyperactivity Disorder. Bethesda (MD): National Institute of Mental Health, National Institutes of Health, US Department of Health and Human Services; 2003. NIH Publication Number: NIH 3572.
- Barkley RA, Fischer M, Smallish L, et al. Young adult outcomes of hyperactive children: adaptive functioning in major life activities. J Am Acad Child Adolesc Psychiatry. 2006;45(2):192-202.
- American Academy of Pediatrics. Clinical practice guidelines: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. Pediatrics 2000;105:1158-1170.
- Biederman J, Faraone SV. The Massachusetts General Hospital studies of gender influences on attention-deficit/hyperactivity disorder in youth and relatives. Psychiatr Clin North Am. 2004;27(2):225-32.
- Biederman J, Mick E, Faraone SV. Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic. Am J Psychiatry. 2002;159(1):36-42.
- Biederman J, Lopez FA, Boellner SW, et al. A randomized, double-blind, placebo-controlled, parallel-group study of SL1381 (Adderall XR) in children with attention deficit/hyperactivity disorder. Pediatrics. 2002;110(2 Pt 1):258-266.
- Elia J. Attention deficit/hyperactivity disorder: pharmacotherapy. Psychiatry. 2005;2:27-35.
- Spencer T, Wilens T, Biederman J, et al. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study. Clin Therapeutics. 2006;266-279.
- Wigal SB, McGough JJ, McCracken JT, et al. A laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children with attention deficit/hyperactivity disorder. J Attent Dis. 2005;9(1):275-289.
- Tulloch SJ, Zhang Y, McLean A, et al. SLI381 (Adderall XR), a two-component, extended-release formulation of mixed amphetamine salts: bioavailability of three test formulations and comparison of fasted, fed, and sprinkled administration. Pharmacotherapy. 2002;22(11):1405-1415.
- ADDERALL XR [package insert], Shire US, Inc. 2004.
- PUBMED [database online]. Bethesda, MD: US National Library of Medicine; 2006. Available at http://www.ncbi.nlm.nih.gov/entrez/query.fcgi. Accessed July 19, 2006.
|
|
 |
|
| |
|
